






































MagnetOs, Vitoss, and Novabone in a Multi-endpoint
Study of Posterolateral Fusion
A True Fusion or Not?
Lukas A. van Dijk, MSc,*† Florence Barrère-de Groot, PhD,*
Antoine J.W.P. Rosenberg, MD, PhD,† Matthew Pelletier, PhD,‡ Chris Christou, PhD,‡
Joost D. de Bruijn, PhD,*§ and William R. Walsh, PhD‡
Study Design: This study was a multi-endpoint analysis of bone graft
substitutes implanted as a standalone graft in a clinically relevant
Ovine model of instrumented posterolateral spinal fusion (PLF).
Objective: The objective of this study was to obtain high-quality
evidence on the efficacy of commercial bone graft substitutes
compared with autograft in instrumented PLF using a state-of-
the-art model with a complete range of assessment techniques.
Summary of Background Data: Preclinical and clinical data on
the quality of spinal fusions obtained with bone graft substitutes
are often limited. Calcium phosphates with submicron top-
ography have shown promising results in PLF, as these are able
to induce bone formation in tissues distant from the host bone,
which facilitates bony union.
Methods: Nine female, skeletally mature sheep (4–5 y) underwent
posterior pedicle screw/rods instrumented PLF at L2–L3 and L4–
L5 using the following bone graft materials as a standalone graft
per spinal segment: (1) biphasic calcium phosphate with submicron
topography (BCP<µm), (2) 45S5 Bioglass (BG), and (3) collagen-β-
tricalcium phosphate with a 45S5 Bioglass adjunct (TCP/BG).
Autograft bone (AB) was used as a positive control treatment.
Twelve weeks after implantation, the spinal segments were evaluated
by fusion assessment (manual palpation, x-ray, micro-computed
tomography, and histology), fusion mass volume quantification
(micro-computed tomography), range of motion (ROM) testing,
histologic evaluation, and histomorphometry.
Results: Fusion assessment revealed equivalence between AB and
BCP<µm by all fusion assessment methods, whereas BG and TCP/
BG led to significantly inferior results. Fusion mass volume was
highest for BCP<µm, followed by AB, BG, and TCP/BG. ROM
testing determined equivalence for spinal levels treated with AB and
BCP<µm, while BG and TCP/BG exhibited higher ROM. Histo-
logic evaluation revealed substantial bone formation in the inter-
transverse regions for AB and BCP<µm, whereas BG and TCP/BG
grafts contained fibrous tissue and minimal bone formation. His-
tologic observations were supported by the histomorphometry data.
Conclusions: This study reveals clear differences in efficacy be-
tween commercially available bone graft substitutes, emphasizing
the importance of clinically relevant animal models with multi-
endpoint analyses for the evaluation of bone graft materials. The
results corroborate the efficacy of calcium phosphate with sub-
micron topography, as this was the only material that showed
equivalent performance to autograft in achieving spinal fusion.
Key Words: synthetic bone grafts, posterolateral fusion, pre-
clinical model
(Clin Spine Surg 2020;00:000–000)
Spinal fusion procedures involve the use of bone graftsto mechanically and biologically conjoin ≥ 2 consec-
utive spinal segments. Posterolateral spinal fusion (PLF) is
one of the more challenging bone grafting indications
performed clinically, because it requires the formation of a
large, consolidated bone mass through the paraspinous
soft tissues with limited host bone contact. To avoid ad-
verse effects related to the harvesting of iliac crest–derived
bone graft,1 synthetic bone graft materials are used as
extenders or substitutes of autograft bone (AB). Numer-
ous synthetic bone grafts are available on the market, of
which many are based on calcium phosphate and bio-
active glass.2,3 Calcium phosphate materials are suitable
bone graft materials due to their similar composition and
structure to mineralized inorganic bone matrix, which
Received for publication May 29, 2019; accepted November 18, 2019.
From the *Kuros Biosciences, Bilthoven; †Department of Oral and
Maxillofacial Surgery, University Medical Center Utrecht, The
Netherlands; ‡Surgical and Orthopaedic Research Laboratories,
Prince of Wales Clinical School, University of New South Wales,
Sydney, NSW, Australia; and §School of Engineering and Materials
Science, Queen Mary University of London, London, UK.
Supported by the European Union’s Horizon 2020 Research and Innovation
program (grant agreement no. 674282) and Kuros Biosciences BV.
L.A.v.D., F.B.-d.G., and J.D.d.B. are employees of Kuros Biosciences
BV. J.D.d.B. is a stockholder of Kuros Biosciences BV. The re-
maining authors declare no conflict of interest.
Reprints: William R. Walsh, PhD, Surgical and Orthopaedic Research
Laboratories, Prince of Wales Clinical School, Edmund Blacket
Building, Avoca Street, Gate 6 Prince of Wales Hospital, Randwick
NSW 2031, Sydney, Australia (e-mail: w.walsh@unsw.edu.au).
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health,
Inc. This is an open-access article distributed under the terms of the
Creative Commons Attribution-Non Commercial-No Derivatives
License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be
changed in any way or used commercially without permission from
the journal.
PRIMARY RESEARCH
Clin Spine Surg  Volume 00, Number 00, ’’ 2020 www.clinicalspinesurgery.com | 1
facilitates excellent osteoconductive and bone-bonding
properties.4 Besides this, specific surface characteristics of
calcium phosphates have been shown to strongly affect
bone regeneration in vivo. Submicron size and morphol-
ogy of calcium phosphate surface features have been
linked to an ability to induce bone formation in tissues
distant from host bone without the addition of stem cells
or growth factors, resulting in enhanced performance in
orthotopic sites.5–9 Bioactive glasses have been shown to
release ionic dissolution products that can stimulate the
activity of osteogenic cells in vitro,10–12 termed osteosti-
mulation. Bioactive glasses have also been shown to elicit
deposition of a crystalline calcium phosphate surface layer
in simulated body fluid,13,14 which has been related to
osteoconduction and strong bone-bonding in vivo.15,16
Although different types of bioactive glass have been
studied in recent years, 45S5 bioactive glass (ie, Bioglass)
developed by Hench and colleagues has been most well-
known as a bone graft substitute material.3
The selection of the most appropriate bone graft for
PLF may be challenging for surgeons, because preclinical
studies on these materials have mostly been performed in
nonclinically relevant models. Few studies have compared
materials from different classes of synthetic bone grafts (eg,
calcium phosphate, Bioglass) in spinal fusion models
in vivo. However, side-by-side comparison of such materials
in well-designed, clinically relevant animal models could
provide valuable insights that could aid surgeons in the se-
lection of treatment options for spinal surgery.
Recently, this research team demonstrated equiv-
alent performance between a calcium phosphate with
submicron topography and the gold standard, autograft,
in clinically relevant animal models of PLF.17,18 One of
these studies involved a challenging Ovine model of in-
strumented PLF with implantation as a standalone bone
graft. In the current work, this Ovine PLF model was
again utilized to compare 3 commercially available bone
grafts based on calcium phosphate and 45S5 Bioglass. The
groups included were (1) a putty formulation of BCP
(biphasic calcium phosphate) with submicron surface
topography, previously shown to have equivalent perfor-
mance to autograft in this model,17,18 (2) a putty
formulation of 45S5 bioactive glass, (3) a collagen-β-tri-
calcium phosphate (βTCP) composite with a 45S5 bio-
active glass adjunct. AB was included as the “gold
standard” reference treatment. Twelve weeks following
implantation, the treated segments were evaluated by a
range of assessment methods, including fusion assessment
[manual palpation, x-ray, micro-computed tomography
(CT), and histology], biomechanical range of motion
(ROM) testing, fusion mass volume quantification (micro-
CT), histologic evaluation of tissue responses, and histo-
morphometry of bone tissue and residual graft material.
METHODS
Materials
Three commercially available bone grafts were ex-
amined in this study. The submicron structured biphasic
calcium phosphate bone graft was provided in a putty
formulation (BCP<µm; MagnetOs Putty; Kuros Bio-
sciences BV, The Netherlands). This formulation con-
tained 1–2 mm calcium phosphate granules with a
submicron surface topography6 and a phase composition
of 65%–75% βTCP and 25%–35% hydroxyapatite, em-
bedded in a fast-resorbing polymer carrier. The polymer
carrier consisted of polyethylene glycol and L‐lactide
monomer and occupied the granule pores and inter-
granular space. MagnetOs Putty is currently not labeled
for use as standalone bone graft in spinal fusion surgery in
the United States.
The bioactive glass-based bone graft was a putty
formulation (BG; Novabone Putty; Novabone Products
LLC) and consisted of ± 70 vol/vol% bioactive glass
(45S5) particles of 32–710 µm in a water-soluble carrier of
polyethylene glycol and glycerin. 45S5 bioactive glass is
composed of ± 45% silica (SiO2), 24.5% calcium oxide
(CaO), 24.5% sodium oxide (Na2O), and 6% phosphorous
pentoxide (P2O5) (wt%).15
The collagen-βTCP composite with 45S5 Bioglass
(TCP/BG; Vitoss BA2X Foam pack, Orthovita Inc.) was
comprised of a bovine type I collagen carrier containing
βTCP particles (≥ 95%–100% βTCP) of 1–4 mm, with a
separate vial of 1.5 g 45S5 bioactive glass particles of
90–150 µm. The implant was prepared according to the
instructions for use. In short, the bioactive glass particles
were loaded onto the collagen-βTCP composite, after
which physiological saline was added, and the composite
was thoroughly mixed. The final composition of the graft
was ± 55% βTCP, 27% 45S5, and 18% collagen (wt%).
Animal Study
A previously described Ovine model of 2-level in-
strumented PLF was used in this study.18 Nine female,
skeletally mature sheep (Ovis Aries, Border Leicester
Merino Cross, 4–5 y, 80–90 kg) were used at the Uni-
versity of New South Wales, Australia, following approval
from the local Animal Care and Ethics Committee
(ACEC). The animals were randomly allocated treatments
at levels L2–L3 and L4–L5 according to a randomization
scheme, with n= 6 for AB, n= 6 for BCP<µm, n= 3 for
BG, and n= 3 for TCP/BG. After the administration of
appropriate antibiotics, analgesics, and anesthetics, sur-
gery was performed, as previously described.18 In brief,
the animal was positioned in sternal recumbency and
draped using sterile technique. The correct levels were
identified and marked preoperatively using fluoroscopy. A
skin incision was made in the dorsal midline, after which
facet joints and transverse processes (TPs) for the relevant
levels were exposed and decorticated. The 2 operative
levels (L2–L3 and L4–L5) were instrumented bilaterally
with polyaxial pedicle screws (Ø 5.5×25 mm) and solid
titanium rods (Ø 5.5 mm). Thereafter, 2 single-level post-
erolateral arthrodeses were performed at the exposed
levels. For each graft material, 10 cm3 of material was
placed into both posterolateral gutters (20 cm3 total per
level) at the appropriate level in direct apposition with the
decorticated TPs, spanning the intertransverse process
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space. Corticancellous autograft was obtained from the
bilateral Os Iliums using rongeurs, after removal of the
cortex. Autograft was reduced to 2–5 mm bone chips that
were mixed to obtain a 1:1 ratio of both donor sites. The
surgical sites were closed in layers. Postoperatively, the
animals were monitored and received proper post-
operative care, antibiotics, and analgesics. At 12 weeks’
follow-up, animals were anesthetized and euthanized by
lethal injection of Lethobarb (325 mg/2 kg intravenously).
The lumbar spines were excised and harvested for end-
point analyses.
Manual Palpation
Directly after harvesting of the spines and removal
of the pedicle rods, 2 trained observers assessed fusion
rigidity of the treated spinal levels in a blinded manner by
manual palpation, as previously described.19 All levels
were graded as fused (rigid, low mobility) or not fused (not
rigid, high mobility) in lateral bending (LB) and flexion-




Harvested spines were radiographed in the poster-
oanterior plane using a Faxitron (Faxitron Bioptics LLC,
Tucson, AZ) and digital plates (Agfa CR MD 4.0 cassette;
Agfa, Germany). An Agfa Digital Developer and work-
station was used to process the digital images (Agfa CR
75.0 Digitizer Musica; Agfa). The radiographic status of
the spinal arthrodesis was evaluated by 2 experienced
observers in a blinded manner on anteroposterior radio-
graphs using the Lenke 4-point grading scale20 (Table 1).
Micro-CT
Micro-CT was performed on the spines using an
Inveon Scanner (Siemens Medical Solutions USA Inc.,
Knoxville, TN). Scans were made with a slice thickness of
53 µm and were stored in DICOM format. Three-
dimensional reconstructions were generated from the
scans. Status of the spinal arthrodesis was evaluated by 2
experienced observers in a blinded manner in 3 orthogonal
planes (ie, axial, sagittal, coronal) and anterior and pos-
terior 3-dimensional reconstructions. As for the radio-
graphs, the Lenke 4-point grading scale was used to grade
fusion status.
Quantification of Fusion Mass Volume
Fusion mass volume quantification was performed
on TIFF stacks generated from the DICOM scans of the
treated spinal levels using dedicated image computing
software (3D Slicer 4.1021). This was achieved by per-
forming manual, intensity-based selection of the separate
left and right fusion masses on interspersed axial slices (53
µm) throughout the micro-CT files, taking care to exclude
the host vertebrae and TPs. Subsequently, interpolation of
boundaries between adjacent scan layers was performed
using a contour interpolation algorithm,22 resulting in
segmentations of the fusion mass. The total volume of
each fusion mass in cm3 was derived from the number of
voxels in each segmentation, including both (new) miner-
alized bone and residual graft material.
Biomechanical Analysis
Nondestructive biomechanical ROM testing was
performed to obtain a multidirectional flexibility profile of
the treated spinal levels. After removal of the pedicle rods,
each of the spinal levels was mounted onto a 6-axis sim-
VITRO robotic musculoskeletal simulator (Simulation
Solutions Ltd, Stockport, UK and Cleveland Clinic Bio-
robotics Lab, Cleveland, OH). A ±7.5 Nm pure moment
was applied to the spinal levels in LB, FE, and axial ro-
tation (AR). Each loading profile was repeated 3 times,
and a mean value for LB, FE, and AR was recorded in the
ROM degrees.
Histology and Histomorphometry
Following mechanical testing, spines were fixed at
room temperature in 10% formalin in 0.145M phosphate-
buffered saline under gentle rotation for at least 96 hours.
Subsequently, specimens were processed for poly-
methylmethacrylate embedding. A Leica SP1600 saw mi-
crotome was used to cut sections in the sagittal plane from
the region between TPs lateral of the spine at both sides.
From each side, a minimum of 3 sections separated by
300 µm was obtained. A histologic staining of methylene
blue (Sigma; 1% in 0.1M borax buffer, pH 8.5) and basic
fuchsin (Sigma; 0.3% in demi water) was performed to
visualize bone tissue (bone matrix: pink, fibrous tissues:
blue). Sections were examined under a Leica microscope
(Eclipse 50i; Nikon) and were scanned with a slide scanner
(DiMage scan 5400 Elite II; Konica Minolta, Tokyo, Japan)
to obtain low-magnification overviews.
Histologic Evaluation and Fusion Assessment
Histologic evaluation included qualitative assess-
ment of the tissue response, including evidence of in-
flammation, evidence of graft resorption, new bone
formation, and bone marrow space development. Low-
magnification overviews of each section were used for
fusion assessment and histomorphometry. Fusion assess-
TABLE 1. Fusion Grading Scale for X-Ray and Micro-Computed Tomography Assessment Based on the Lenke Classification20
Grade Definition
A Bilateral robust bridging fusion masses (definitely solid)
B Unilateral robust bridging fusion mass and contralateral thin fusion mass (probably solid)
C Unilateral thin bridging fusion mass and probable pseudarthrosis on the contralateral aspect (probably not solid)
D Bilateral thin fusion masses with obvious pseudarthrosis or bone graft resorption (definitely not solid)
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ment by histology was performed by 2 trained observers in
a blinded manner on 3 sections from each lateral side of
the treated spinal level, resulting in 2 scores per level. Each
section was scored as histologically fused if a continuous
bridge of bone tissue was observed between the TPs of L2–L3
or L4–L5, thus connecting the adjacent spinal levels. When at
least 1 of the 3 sections was scored as fused, the sample was
considered “fused” on that side of the spine. If no fusion was
determined in any of the 3 slides, the sections were digitally
stacked and reevaluated for fusion.
Histomorphometry
Histomorphometry of the fusion mass was per-
formed on 3 sections from each side of the treated spinal
level. Pixels representing bone (B) and remaining implant
material (M) in a region of interest (ROI) were pseudo-
colored using image editing software (Adobe Photoshop
5.0). Next, the number of pixels for B, M, and ROI was
recorded, and the area percentage of bone in the available
space was calculated by the following formula: B/(ROI−M)×
100%. In addition, the area percentage of remaining
implant material was calculated by the following formula:
M/ROI×100%.
Statistical Analysis
Statistical analysis of data was performed using
dedicated software tools (GraphPad Prism, San Diego,
CA; SPSS Inc., Chicago, IL). Fusion grading data from
manual palpation, x-ray, micro-CT, and histology were
analyzed by the Fisher-Freeman-Halton exact test. Data
from micro-CT volume quantification, biomechanical
ROM testing, and histomorphometry were analyzed by
analysis of variance followed by Tukey honest significant
difference test for post hoc analysis. Normal distribution
of data was assessed by the Shapiro-Wilk normality test.




All surgeries and study procedures proceeded as
planned. All graft materials handled well, as they were
moldable and easy to implant into the posterolateral
gutters. No adverse events occurred in any animal during
surgery and the 12-week follow-up period.
Manual Palpation
Results of fusion assessment by manual palpation
are presented in Table 2. Successful arthrodesis was
confirmed in all levels treated with AB, with 100% of
specimens graded as rigid in both LB and FE. Results
varied between treatment groups. Although BCP<µm
showed a similar fusion rate to AB with all specimens
scored as rigid, both bone grafts (BG and TCP/BG)
containing bioactive glass were graded as rigid in only 1 of
3 treated levels. All fusion grades by manual palpation
were coherent between reviewers and between the different
modes LB and FE. The difference between groups was
confirmed by statistical analysis.
Radiographic Evaluation and Fusion Assessment
Faxitron radiographs (Fig. 1) were evaluated for
evidence of bone formation and residual graft material in
the posterolateral regions in between TPs of L2–L3 and
L4–L5. In the AB group (Fig. 1A), a consolidated mass of
mineralized bone was observed in the bilateral intertransverse
process regions. Individual autogenous bone particles could
not be discriminated. In the BCP<µm group (Fig. 1B), a large,
radiopaque fusion mass was evident in the region between
the bilateral TPs. Although individual BCP<µm particles
could still be discriminated, the grafts had consolidated
into a dense, continuous fusion mass between the TPs. At
levels treated with BG (Fig. 1C), thin masses of radiopaque
material, which were of variable intensity and continuity,
were observed between TPs. In the TCP/BG group
(Fig. 1D), there was a significant lack of radiopaque
substance in the intertransverse regions of all treated levels.
The TCP/BG grafts had a low radiopacity with a granular
appearance and did not form a consolidated mass at the
treated levels.
On micro-CT reconstructions (Fig. 2), a bony fusion
mass forming a bridge between L2–L3 or L4–L5, was
commonly observed in the AB group (Fig. 2A). In many
cases, the fusion masses were well-developed, showing a
smooth, continuous bone mass with a de novo cortex.
Occasionally, fusion masses were not yet completely
consolidated and matured, as an outer cortex had not
yet developed, and autograft chips could be distinguished
in the developing bone mass. The BCP<µm grafts (Fig. 2B)
formed uniform, solid, and continuous fusion bridges
between the TPs. The center of the BCP<µm grafts was
compact, and individual BCP particles could be hardly
TABLE 2. Outcomes of Fusion Assessment Per Evaluation Method
Methods AB BCP<µm BG TCP/BG Significance (P)*
Manual palpation 6/6 6/6 1/3 1/3 0.013
X-ray A: 4/6 A: 5/6 B: 2/3 C: 1/3 0.008
B: 2/6 B: 1/6 D: 1/3 D: 2/3
Micro-CT A: 3/6 A: 5/6 B: 2/3 C: 1/3 0.010
B: 3/6 B: 1/6 D: 1/3 D: 2/3
Histology 9/12 10/12 0/6 0/6 < 0.001
*Fisher-Freeman-Halton exact test.
AB indicates autograft bone; BCP<µm, biphasic calcium phosphate with submicron topography; BG, Bioglass; CT, computed tomography; TCP, tricalcium phosphate.
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distinguished on axial, sagittal, and transversal slices,
indicating bone formation between the granules. New
bone growth into the calcium phosphate grafts could be
observed in the regions near the host bone.
The spinal levels treated with BG (Fig. 2C)
presented thin, underdeveloped fusion masses versus AB
and BCP<µm, as observed by micro-CT. The radiopaque
mass, in the region between TPs (if present), had a fine,
granular appearance with localized, dense regions in the
center or in apposition with TPs. A continuous mass
between TPs was lacking, and Bioglass granules were few
and dispersed. None of the treated levels presented a
consolidated fusion mass between TPs with TCP/BG
(Fig. 2D). A small amount of dispersed, granular material
was occasionally observed in the intertransverse regions.
In some cases, regions of minor osteoconductive bone
growth were observed near the host bone.
Results of fusion grading on radiographs and micro-
CT according to the Lenke scale are presented in Table 2.
Both AB and BCP<µm obtained high fusion scores, with
either unilateral or bilateral robust bone bridging in all
treated levels. Radiographic fusion scores were lower in the
other groups, while the BG group obtained more favorable
grades than TCP/BG. The differences in radiographic fusion
grades reached statistical significance, although no between-
group comparisons were analyzed.
Fusion Mass Volume
Micro-CT quantification (Fig. 2E) revealed that the
levels treated with AB had an average unilateral,
mineralized fusion mass volume of 5.70±1.59 cm3. The
volume in the BCP<µm group was significantly higher at
9.60±0.45 cm3. Volumes were significantly lower in BG and
TCP/BG, at ∼3 cm3. Statistical significance was reached for
all group comparisons, except for BG versus TCP/BG.
Biomechanical Testing
Functional treatment efficacy was quantified by use
of biomechanical ROM testing (Fig. 3). The BCP<µm
group revealed an equivalent ROM to AB in all modes,
while ROM for levels treated with BG and TCP/BG was
evidently higher in LB and FE. Statistical analysis revealed
equivalence between AB and BCP<µm in all modes, while
ROM in these groups was significantly lower in LB and FE
compared with BG and significantly lower in FE compared
FIGURE 1. Representative examples of faxitron radiographs of the spinal levels treated with AB (A), BCP<µm (B), BG (C), and TCP/
BG (D), after removal of instrumentation. AB indicates autograft bone; BCP<µm, biphasic calcium phosphate with submicron
topography; BG, Bioglass; TCP, tricalcium phosphate.
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FIGURE 2. Representative examples of 3-dimensional micro-computed tomography reconstructions (A–D) of spinal levels treated,
AB (A), BCP<µm (B), BG (C), and TCP/BG (D). The host spinal bone (off-white) and fusion mass (gray) including (new) bone and
residual implant material are shown as individual segmentations. For each treatment group, unilateral fusion mass volume (bone+
graft material) was determined by performing voxel-based quantification (E). Data shown as mean and SD. •, significantly different
from AB, BG, and TCP/BG (P<0.001). ★, significantly different from BCP<µm, BG, and TCP/BG (P<0.001). AB indicates autograft
bone; BCP<µm, biphasic calcium phosphate with submicron topography; BG, Bioglass; TCP, tricalcium phosphate.
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with TCP/BG. No significant difference in AR ROM was
determined between all treatments.
Histologic Evaluation and Fusion Assessment
Histology of the spinal levels treated with AB
(Fig. 4A) revealed the presence of abundant new and
remodeling bone tissue in the intertransverse process space.
The implanted AB particles had been remodeled into
uniform bone mass in the intertransverse process space.
In BCP<µm specimens (Figs. 4B, 5A–D), a large area
consisting of calcium phosphate granules integrated in
trabecular bone was observed throughout the implant sites
(Fig. 4B). Bone was of mature, lamellar morphology
including new bone marrow spaces (Figs. 5A–C) and
evidence of a pseudocortex in some specimens (Fig. 5D).
The bone matrix was in direct apposition with the BCP<µm
material. Typical bone cells, including osteoblasts lining
regions of new bone formation, osteoclasts, and osteocytes
were observed throughout the specimens (Fig. 5C)
Multinucleated cells were observed resorbing the calcium
phosphate material on granule surfaces not covered by bone
(Fig. 5C).
Histology of the BG specimens (Figs. 4C, 5H–K)
presented as fibrous tissue with dispersed Bioglass particles
and absence of bone tissue throughout the implant site
(Fig. 4C). Residual Bioglass particles were contained in
fibrous tissue and commonly contained cracks, sometimes
having a hollow center, or were fragmented (Fig. 5H).
Occasional osteoconductive bone formation was observed
in the vicinity of host TPs (Fig. 5E). However, sometimes,
no osteoconductive bone formation was observed even
when Bioglass was in direct apposition with the host bone
(Fig. 5G). In 5 of 6 specimens, a foreign body reaction was
observed around Bioglass particles throughout the implant
sites, characterized by encapsulation by granulatomous
inflammatory tissue with presence of lymphocytes and
foreign body giant cells (Figs. 5I–K). Moreover, 3 of 6
specimens contained dense regions of Bioglass of variable
dimensions, which upon further inspection revealed to be
areas of severely fragmented material and evidence of foreign
body reaction (Fig. 5J).
For TCP/BG (Figs. 4D, 5L–P), most sections had to
be obtained from regions very medial to the spinal body,
as graft material or bone in the regions between TPs was
largely absent (Fig. 4D). The implantation sites contained
fibrous tissue with sparse calcium phosphate particles,
which were commonly in the process of disintegration due
to cell-mediated resorption (Figs. 5N–O). The Bioglass
particles were very small and could only be observed by



























































FIGURE 3. Diagrams of nondestructive biomechanical range of motion testing results, as performed in lateral bending (A), flexion-
extension (B), and axial rotation (C). Data are presented as range of motion degrees in mean and SD.★, significantly different from
AB and BCP<µm (P<0.005). •, significantly different from AB and BCP<µm (P<0.05). ▪, significantly different from AB and BCP<µm
(P<0.005). AB indicates autograft bone; BCP<µm, biphasic calcium phosphate with submicron topography; BG, Bioglass; TCP,
tricalcium phosphate.
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observed in the BG group (Figs. 5L–P). An inflammatory
reaction around the Bioglass particles was generally
not observed. Newly formed bone tissue was absent
in the central region of the implants, although some
specimens exhibited new bone formation in the vicinity of
TPs. Calcium phosphate and Bioglass particles were
occasionally observed being integrated in the bone
matrix (Figs. 5L–M). One specimen presented a region
with graft material enclosed by granulatomous tissue that
contained high numbers of lymphocytes and resorbing
multinucleated giant cells, indicating a foreign body granuloma
(Fig. 5P).
Results of fusion assessment by histology are pre-
sented in Table 2. Histologic fusion scores in the AB and
BCP<µm groups were significantly higher than in the BG
and TCP/BG groups. For levels treated with AB, the
positive control, fusion was reported in 9 of 12 samples,
corresponding to a fusion rate of 75%. In the BCP<µm
group, 10 of 12 samples were scored as fused, which
translates to a fusion rate of 83%. For the BG and TCP/BG
groups, a bony fusion between TPs was not reported in any
of the specimens, thus corresponding to a fusion rate of 0%.
Statistical analysis revealed that the differences in histologic
fusion rate were statistically significant (P< 0.05).
Histomorphometry
As determined by histomorphometry (Fig. 6), the
fusion masses of levels treated with AB and BCP<µm
contained a substantially higher percentage of bone, as
compared with the BG and TCP/BG groups (Fig. 6A).
Bone proportions were similar for AB and BCP<µm, with
over > 40% of bone in the available space in both groups.
This percentage was significantly lower for the other groups,
the lowest being BG, followed by TCP/BG. Statistical
analysis confirmed equivalence for AB versus BCP<µm and
BG versus TCP/BG, while all other comparisons were
significantly different. Area percentage of remaining graft
material (Fig. 6B) was highest for BCP<µm implants,
followed by BG, with the TCP/BG graft having the lowest
percentage. Statistical significance was reached for all group
comparisons in material percentage.
DISCUSSION
The posterolateral spine environment is a challeng-
ing biological and biomechanical environment, as it pro-
vides limited host bone contact and significant exposure to
soft tissues. Even with use of the “gold standard” of au-
tograft, surgeons commonly deal with revision surgery
rates of ± 10%–20%.23–26 Considering this, it is important
that the selection of graft materials is based on preclinical
evidence obtained in studies of high methodological
quality, using clinically relevant animal models and mul-
tiple evaluation techniques. A large number of bone grafts
are commercially available for clinical use, which makes
selection of the most appropriate challenging for the sur-
geon community. Most reports on commercial graft ma-
terials in the literature are of preclinical studies performed
in rabbits, and they involve the repair of small, cancellous
bone defects with a high ratio of bone surface to defect
volume.27–33 Although critically sized, that is, they will not
completely spontaneously heal without the use of a graft,
such defects are less challenging than, and do not properly
model, the posterolateral spine environment. This limits
the extrapolation of results from these models to PLF
indications. Moreover, many studies have been of poor




FIGURE 4. Representative, low-magnification micrographs of sagittal histologic sections (methylene blue/basic fuchsin) taken
from the intertransverse process regions of spinal levels treated with AB (A), BCP<µm (B), BG (C), and TCP/BG (D). Bone matrix
is shown in pink, soft tissues in blue, residual calcium phosphate material in black, and Bioglass particles are translucent. The low-
magnification micrographs were graded for fusion, evident from a continuous bone bridge between adjacent transverse processes.
AB indicates autograft bone; BCP<µm, biphasic calcium phosphate with submicron topography; BG, Bioglass; TCP, tricalcium
phosphate.
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methodological design, for example, no use of critical-
sized defects, lack of proper positive and/or negative
controls, and use of limited endpoints and assessment
methods with low sensitivity.27–29,34 Clinical reports for
the use of synthetic bone grafts are limited in number and
often of low methodological strength (ie, observational
studies). Furthermore, outcomes can only be determined
using techniques with low sensitivity and/or specificity,
such as radiographic evaluation and patient-reported
outcomes.
Of the available animal models of PLF, the in-
strumented Ovine PLF35 model is among the most trans-
lational, as bone remodeling properties and spine
biomechanics of sheep are similar to those of humans, and
the model allows the use of relevant graft volumes and
pedicle instrumentation.36–39 For comparison, the Boden
rabbit PLF model,19 which is used to obtain market ap-
proval for bone graft materials in the United States, is
noninstrumented and differs in anatomy, biomechanics,
and bone turnover rate from the clinical reality in
humans.40 Note, the current study used aged sheep (4–5 y
old), which challenges the model due to age.41
With regard to assessment techniques used for fusion
evaluation, it is important that a range of different methods is
applied, as they may individually give limited information and
vary in sensitivity. Classically, fusion assessment in preclinical
models was performed by the less sensitive techniques of
manual palpation and plain film radiography.19 Recently,
more sensitive techniques have been added, including micro-
CT, histology, and biomechanical testing. For synthetic bone
grafts, fusion evaluation by radiography (eg, x-ray, CT) may
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FIGURE 5. Representative micrographs from histologic sections of the spinal levels treated with BCP<µm (A–D), BG (E–K), and TCP/
BG (L–P). Micrographs were obtained from regions near the host transverse process (A, E–G, L, M) and the intertransverse central
region (B, C, H–K, N–P). A pseudocortex on the outside of the fusion mass was observed in specimens treated with BCP<µm (D—
blue arrows). High-magnification images show cellular processes observed near the graft materials, including osteoblasts (C, F, M—
black arrows) depositing osteoid and cell-mediated resorption of materials by multinucleated cells (C, O, P—yellow arrows).
Inflammatory foreign body reaction was observed in BG and TCP/BG specimens, as evidenced by encapsulation of material (I),
high numbers of lymphocytes (I, P) and foreign body giant cells (I–K, P—yellow arrows). BCP<µm indicates biphasic calcium
phosphate with submicron topography; BG, Bioglass; BM, bone marrow; FT, fibrous tissue; HB, host bone; NB, new bone; O,
osteoid; TCP, tricalcium phosphate.
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radiopaque implant materials cannot easily be distinguished
by these methods. Histology provides a unique insight and
accurate representation of a fusion mass at the tissue and cell
level, allowing investigators to differentiate between bone and
graft material and to evaluate tissue and cellular responses.
Last, biomechanical testing is an important quantitative
method performed in conjunction with the other techniques to
determine whether fusion outcomes also have a functional
significance, that is, reduction of mobility between spinal
segments. Here, a robotic musculoskeletal simulator was used
to apply controlled loading regimens to the spinal segments.
Using this validated, multi-endpoint, clinically rel-
evant, Ovine model of instrumented PLF, 3 commercially
available bone grafts implanted as a standalone graft
were compared against AB, the current gold standard for
bone grafting. Of the evaluated synthetic bone grafts,
BCP< µm was the only material that presented substantial,
solid fusion masses between TPs that contained mature
bone, resulting in similar fusion scores to AB by all as-
sessment methods and equivalent biomechanical ROM.
These outcomes were corroborated by all assessment
techniques and were in line with previous results.17,18 In
contrast to BCP< µm, spinal levels treated with BG and
TCP/BG significantly underperformed to the positive
control by all evaluation methods. Although by bio-
mechanical testing no significant differences between
treatments were determined in AR, it is recognized that
flexibility testing in AR has a lower sensitivity than the
other modes.42,43
These results confirm the limitations of fusion evalu-
ation by radiographic techniques when synthetic bone graft
materials are used in PLF. Although spinal levels treated
with BG obtained a moderate fusion grade B of the Lenke
scale in 2 of 3 specimens by both x-ray and micro-CT,
histology revealed that all apparent fusion bridges did not
contain any bone tissue. These results show that the option
to use histology is a significant advantage of preclinical
models over clinical investigation. Histology also allows the
evaluation of local tissue reactions, as the materials resorb
and participate in the bone repair and remodeling process,
which is not possible by other techniques.
Fusion mass volume quantification is a more novel
method for evaluation of PLF outcomes that assists in further
differentiation of radiographic endpoints. It should be noted
that the use of micro-CT, which is not available clinically,
provides a level of detail beyond traditional radiographs or
clinical CT. The technique can provide meaningful in-
formation on graft volume stability, as too fast or too severe
resorption of a graft may potentially result in atrophic
pseudarthrosis.44 Here, clear differences in fusion mass vol-
umes were determined between groups. Although the same
starting volume of 10 cc was implanted in each posterolateral
gutter for all groups, the mineralized volume after 12 weeks
was around 3 cm3 for BG and TCP/BG grafts, whereas for
BCP<µm, it was just under 10 cm
3. Although the initial ra-
diopaque volume of the grafts was not determined and the
data represent the volume of both new bone and residual graft
material, we may still assume that BG and TCP/BG have
undergone substantial resorption after implantation. This
notion was supported by histologic observations and histo-
morphometry results. The finding that spinal levels treated
with AB had lower fusion mass volumes compared with
BCP<µm may be potentially related to a lower initial radio-
paque volume, but could also suggest resorption. Indeed, AB
has been reported to undergo resorption and remodeling after
implantation in the posterolateral spine, leading to a volume
loss of up to ±35% during the first year.45–47
The above findings demonstrate a clear difference in
the performance of commercially available synthetic bone
grafts in instrumented PLF in sheep. Correlation of per-
formance outcomes to specific bone graft factors is chal-
lenging due to the many physicochemical differences
between the grafts that could affect bone regeneration
potential, for example, composition, surface properties,
carrier materials, particle size, and graft to carrier ratio.
However, the submicron surface topography of BCP<µm
seems to play a leading role in bone graft performance48





































FIGURE 6. Histomorphometry diagrams of bone (A) and residual material (B) performed on low-magnification micrographs of
histologic sections. Data are presented as area%, in mean and SD. ★, significantly different from BG and TCP/BG (P<0.001). •,
significantly different from BG (P<0.005) and TCP/BG (P<0.001). ▪, significantly different from BCP<µm (P<0.005) and TCP/BG
(P<0.001). AB indicates autograft bone; BCP<µm, biphasic calcium phosphate with submicron topography; BG, Bioglass; TCP,
tricalcium phosphate.
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In recent years, research has consistently demonstrated
that calcium phosphates with a submicron topography show
enhanced performance to conventional calcium phosphates,
following from their ability to induce bone formation in re-
gions far from host bone or with minimal bone contact.7–9,48
This property is particularly desirable for use in PLF, in which
bone formation should occur in the paraspinous soft tissues
with limited host bone surface contact. A suggested mecha-
nism underlying the enhanced efficacy of calcium phosphates
with submicron topography is the upregulation of anti-in-
flammatory M2 macrophages at the material surface, which
have been associated with bone regeneration (R. Duan, Y.
Zhang, L.A. van Dijk, D. Barbieri, J.J.J.P van den Beucken,
H. Yuan, J.D. de Bruijn, 2019, unpublished data).49–51
Bone induction by the TCP component of the TCP/
BG group has been evaluated in 2 previous studies.48,52
Both studies demonstrated the absence of submicron top-
ography correlated with the lack of ectopic bone induction,
even in the presence of Bioglass.52 Furthermore, the TCP
component in TCP/BG reportedly consists of 100% phase
pure βTCP and has a porosity of 78%.52 A calcium phos-
phate with these properties is expected to have a high re-
sorption rate, with potentially detrimental effects on bone
healing.53 This notion is in agreement with the findings of
the current study and other works.32,33,52,53
The presence of 45S5 Bioglass in BG and TCP/BG
grafts, resulting in enhanced osteoblast activity and osteo-
genic differentiation of stem cells in vitro,10–12,54–56 did not
promote spinal fusion in this l PLF model. To our knowl-
edge, there is no literature on the use of Bioglass as a
standalone graft in PLF models, and beneficial effects of
osteostimulation have not been demonstrated in other
in vivo models. We may, therefore, conclude that osteosti-
mulative Bioglass, whether used alone or as an adjunct to
calcium phosphate, has little biological relevance to use of
bone graft materials in spinal fusion. Moreover, the in-
flammatory foreign body reaction observed around Bioglass
particles, which has also been reported in other studies,57–59
is presumably not beneficial for bone formation. However,
foreign body reaction against Bioglass particles was not
observed in TCP/BG, which contained a lower content of
Bioglass than BG (25% vs. 100%), suggesting that only
larger proportions of Bioglass may induce such reactions.
CONCLUSIONS
Using a challenging, clinically relevant, Ovine model of
instrumented PLF, this study reveals clear differences in per-
formance between commercially available bone graft materi-
als implanted as a standalone graft, after evaluation by a full
range of assessment techniques. The results demonstrated fa-
vorable outcomes with a putty formulation of BCP<µm,
which has a submicron topography, versus 2 other bone graft
materials, being a putty formulation of 45S5 Bioglass and a
collagen-βTCP with a 45S5 Bioglass adjunct. Through all
outcomes, the BCP<µm reached equivalence to the positive
control, autograft, in achieving functional spinal fusion, while
the other 2 materials significantly underperformed, showing
an inability to form a solid, bony fusion between the spinal
segments during the 12-week follow-up period. These results
corroborate previous findings on the efficacy of BCP<µm with
submicron topography in spinal PLF models, following from
its ability to promote bone formation in soft tissues distant
from host bone. These findings emphasize the importance of
side-by-side comparison of commercial bone graft materials in
clinically relevant, multi-endpoint animal models in de-
termining spinal fusion efficacy.
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